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Abstract
Human bocavirus (HBoV) is a parvovirus and detected worldwide in lower respiratory tract infections (LRTIs), but its
pathogenic role in respiratory illness is still debatable due to high incidence of co-infection with other respiratory viruses. To
determine the prevalence of HBoV infection in patients with LRTI in Shanghai and its correlation with disease severity, we
performed a 3-year prospective study of HBoV in healthy controls, outpatients and inpatients under five years of age with X-
ray diagnosed LRTIs. Nasopharyngeal aspirates were tested by PCR for common respiratory viruses and by real time PCR for
HBoV subtypes 1–4. Nasopharyngeal swabs from healthy controls and serum samples and stools from inpatients were also
tested for HBoV1-4 by real time PCR. Viral loads were determined by quantitative real time PCR in all HBoV positive samples.
HBoV1 was detected in 7.0% of inpatients, with annual rates of 5.1%, 8.0% and 4.8% in 2010, 2011 and 2012, respectively.
Respiratory syncytial virus (RSV) subtype A was the most frequent co-infection detected; HBoV1 and RSVA appeared to co-
circulate with similar seasonal variations. High HBoV viral loads (.106 copies/ml) were significantly more frequent in
inpatients and outpatients than in healthy controls. There was a direct correlation of high viral load with increasing disease
severity in patients co-infected with HBoV1 and at least one other respiratory virus. In summary, our data suggest that
HBoV1 can cause LRTIs, but symptomatic HBoV infection is only observed in the context of high viral load.
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Introduction
Human bocavirus (HBoV) was first discovered in the respiratory
secretions of Swedish children with symptoms of acute respiratory
infection (ARI) in 2005 [1]. Since its discovery, HBoV has been
associated with upper and lower respiratory tract infections
(LRTIs) and gastroenteritis worldwide. Recent studies have
revealed that three new species, named HBoV2, 3 and 4 are
found mainly in the gastrointestinal tract and rarely in the
respiratory tract, in contrast to HBoV1 which is a respiratory
pathogen [2,3,4,5]. HBoV is classified in the family Parvoviridae,
which includes small, non-envoloped, icosahedral viruses with
5.3 kb single-strand DNA genome containing three open reading
frames (ORFs). The first two sequential ORFs encode non-
structural proteins NS1 and NP1, whereas the third downstream
ORF encodes two viral capsid proteins, VP1 and VP2 [1].
Evidence is mounting that HBoV1 is an important cause of
LRTIs with clinical symptoms including fever, cough, wheezing,
dyspnea, abdominal pain and diarrhea [6,7,8]. Several seroepide-
miologic studies have demonstrated that the seropositivity rate for
HBoV increases with age, reaching nearly 100% by 6 years of age
[9,10]. Recent data show that HBoV1 is often shed for a long time
after primary infection into the respiratory tracts of infants and
young children. HBoV1 DNA and anti-HBoV1 antibodies in
serum differentiate primary HBoV1 infection from long term post
infection shedding [11], with detection of HBoV1 DNA in blood
more closely associated with symptoms than positive respiratory
samples alone [9].
It is difficult to assess the direct impact of HBoV infection on
LRTIs due to its frequent detection in asymptomatic children and
co-detection with other respiratory viruses in symptomatic
children and few studies have focused on HBoV viral load and
disease severity [12,13]. However, recent studies have implied that
high viral load, detection of HBoV alone and viraemia may be
associated with RTIs [14], with mono-infection of HBoV being
associated with higher viral load than co-infection [15]. Two case
reports about severe respiratory disease found a statistical
association between HBoV1 and otherwise unexplained LRTIs,
in particular, acute wheezing [16,17,18]. This suggests that
HBoV1 infection, although mainly asymptomatic, has the
potential to cause severe disease.
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In the current study, we have used molecular detection and viral
load measurement in a cohort of healthy, outpatient and inpatient
children in Shanghai to determine the association of HBoV viral
load with disease severity, in the absence and presence of other
respiratory infections.
Results
Prevalence of HBoV infection in children in Shanghai,
2009 to 2011
HBoV DNA was detected by real time PCR in 39 out of 554
(7.0%) NPAs from inpatients, 3 out of 29 (10.3%) NPAs from
outpatients and 5 out of 195 (2.6%) nasopharyngeal swabs from
healthy controls. The clinical symptoms of the 3 HBoV-positive
outpatients were fever and cough, without any additional
respiratory viruses detected. Among 554 inpatients, other respi-
ratory viruses detected were RSVA (16.2%,90/554), human
rhinovirus (HRV) (8.8%, 49/554), Adenovirus (AdV) (6.7%, 37/
554), parainfluenza virus-3 (PIV3) (6.1%, 34/554), human
metapneumovirus (hMPV) (3.6%, 20/554), RSVB (3.4%, 19/
554), Coronavirus OC43/HKU1 (2.3%, 13/554), PIV1 (2.2%,
12/554), Influenza virus A (FluA) (1.6%, 9/554), FluB (1.4%, 8/
554), Coronavirus 229E/NL63 (0.9%, 5/554) and PIV2 (0.7%, 4/
554). HBoV DNA was also detected by real time PCR in 6 out 13
(46.2%) stool samples and 6 out 11 (54.5%) serum samples from
inpatients; of these 4 were from ICU, 1 from department of
respiratory medicine and 1 from the neonatal department. The
only subtype detected in all samples was HBoV1.
The inpatient demographics and clinical information are
summarized in Table 1. The median age of HBoV-positive
children was 24 months versus 3 months in HBoV-negative group.
Fever, wheezing, dyspnea and diarrhea were not significantly
different between HBoV-positive and HBoV-negative groups
(Table 1). It is noteworthy that cough and abdominal pain were
recorded in more inpatients with HBoV than inpatients without
HBoV (89.7% vs 70.5%, p#0.05 and 7.7% vs 2.5%, p= 0.095
respectively; Table 1).
HBoV1 was detected in patient NPAs throughout the course of
the study with peak detection in autumn and winter. It was
noticeable that HBoV appeared to co-circulate with RSVA
(Figure 1), which was the most frequently co-detected virus;
however, an extended study with a larger dataset would be
required to confirm such a correlation.
Phylogenetic analysis of HBoV1 circulating in Shanghai,
2009 to 2011
Nine samples with real-time PCR cycle threshold (Ct) value
below 24 were chosen for genome sequencing. Complete genomes
were assembled by PCR followed by sequencing of the PCR
products; the size of the PCR products was 1099 bp, 1019 bp,
1022 bp, 1101 bp and 1279 bp. Phylogenetic analysis suggested
all 9 strains (GenBank accession numbers JN632511-JN632519)
had a close genetic relationship to strain FZ40 from Fuzhou and
strain WLL-1 from Hangzhou, China (GenBank accession
numbers GQ455987 and DQ778300, respectively) (Figure 2). All
Table 1. Clinical and demographic data of inpatients with
and without HBoV.
HBoV+ HBoV2 p Value
Study population 39 515
Age
Median (interquartile) 24M (12M,42M) 3M (25D,12M)
Sex
Male (%) 20 (51.2) 308 (59.8) 0.296m
Clinical (%)
X-ray 39 (100) 515 (100)
Fever 37 (94.9) 497 (96.5) 0.644w
Cough 35 (89.7) 363 (70.5) 0.016m
Wheezing 7 (17.9) 52 (10.1) 0.171m
Dyspnea 17 (43.6) 207 (40.2) 0.677m
Abdominal pain 3 (7.7) 13 (2.5) 0.095w
Diarrhea 4 (10.2) 26 (5.0) 0.152w
HBoV= human bocavirus; M=month, D = day; mMentel-Haenszel x2 test;
wFisher exact x2 test.
doi:10.1371/journal.pone.0062318.t001
Figure 1. Monthly distribution of HBoV, RSVA and total positive samples during study period (Oct.2009-Sep.2012). NPAs collected
from children who were inpatients with LRTI from October 2009 through September 2012 were assayed for 12 common respiratory viruses using the
Seeplex RV12 ACE detection Kit. Samples were separately assayed for HBoV by specific real time PCR kit. The incidence of RSVA and HBoV was plotted
as the aggregate of positive samples for each month over the study period. The solid line with circles represents RSVA, the dashed line with squares
represents HBoV and the dotted line with triangles represents total respiratory virus incidence.
doi:10.1371/journal.pone.0062318.g001
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9 strains belonged to HBoV1, correlating with the results of
subtype real time PCR. Among the 4 subtypes of HBoV, HBoV2
and HBoV4 are grouped together and separate from HBoV1 and
HBoV3.
HBoV co-infection with other respiratory viruses
Of 39 HBoV-positive inpatients, 19 (48.7%) had at least one
additional respiratory virus detected (Table 2). The viruses most
frequently detected simultaneously with HBoV were RSVA in 9
(47.4%), HRV and hMPV in 3 (15.6%) and FluB in 2 (10.5%)
patients. The frequencies of co-detection of one or two additional
viruses in patients with HBoV were 89.5% and 10.5%. To assess
whether this high frequency of co-detection of other respiratory
viruses was a finding specific to HBoV-infected patients, another
41 co-infection samples from LRTI inpatients without HBoV were
analyzed. The most frequently detected viruses among these 41
samples were HRV in 25 (61.0%), AdV in 14 (34.1%), RSVA in
13 (31.8%), hMPV and RSVB in 9 (22.0%) patients. The median
age of HBoV-positive and HBoV-negative individuals of co-
infection patients was 24 months (interquartile range 11–42
Figure 2. Phylogenetic tree of HBoV sequences. Nine samples with real-time PCR cycle threshold (Ct) value below 24 were chosen for genome
sequencing. The nucleotide sequence of HBoV for each sample was PCR amplified, sequenced and analyzed. The phylogenetic tree of HBoV
sequences was constructed using Neighbor-joining method by MEGA (5.0 version) software. The bootstrap percentages are given at the node of each
branch (1000 replicates). Sequences of 6 different HBoV1 subtype, 3 HBoV2 subtype, 3 HBoV3 subtype, 2 HBoV4 subtype were downloaded from
Genbank and used as reference viruses. All the isolates sequenced in this study are indicated by dark circles. The dark triangles represent FZ40 and
WLL-1 strains from Fuzhou and Hangzhou, China, respectively.
doi:10.1371/journal.pone.0062318.g002
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months) and 30 months (interquartile range 24–39 months)
respectively. There were no significant differences in frequencies
of specific respiratory symptoms between the co-infected inpatients
with or without HBoV (Table 2). It is noticeable that in the co-
infected patient group there were fewer HBoV positive patients
than HBoV negative patients with moderate disease (46.3% vs
10.5%, p#0.05) whereas there were more HBoV positive than
negative patients in the group with severe disease (36.8% vs
12.2%, p#0.05) (Table 2).
HBoV viral load is associated with disease severity in
children
Absolute quantification of DNA by real time PCR revealed that
the HBoV viral load in HBoV-positive children was highly
variable, ranging from 1.46103 copies/mL to 5.06109 copies/
mL, with a median value of 3.76106 copies/mL. In order to assess
the association between viral load and disease, 39 NPAs of
inpatients, 3 NPAs from outpatients without any treatment and 5
nasopharyngeal swabs (NPSs) of healthy controls were chosen.
The median viral load of healthy controls, outpatients and
inpatients were 2.76103 copies/mL, 26106 copies/mL and
5.16106 copies/mL, respectively (p#0.05) showing that inpatients
and outpatients had higher loads than healthy controls (Figure 3).
Interestingly, the median viral load in NPAs from inpatients in
whom HBoV was the only virus detected (6.66106 copies/mL)
was not significantly higher than that in inpatients with HBoV co-
infection with other respiratory viruses (2.26106 copies/mL,
p= 0.0637). In accordance with previous studies, we chose
1.06106 copies/mL as the threshold value to differentiate between
high and low viral loads [15]. The median viral load of
symptomatic children, including outpatients and inpatients, was
high whereas the median viral load of asymptomatic children was
low.
The viral loads of 39 HBoV-positive inpatients with mild,
moderate and severe disease in the context of HBoV mono-
infection and HBoV co-infection are shown in Figure 4. The
median viral loads in mild, moderate and severe patients (56105
copies/mL, 1.26107 copies/mL, and 7.66108 copies/mL,
respectively) with only HBoV detected were significantly higher
than viral loads in mild, moderate and severe patients (2.76105
copies/mL, 3.96106 copies/mL, 8.76106 copies/mL, respective-
ly) with HBoV co-detected with other respiratory viruses (p#0.05).
In inpatients infected with HBoV1 alone, the median viral loads
among mild, moderate and severe group were not significantly
different whereas in co-infected inpatients the median vial loads
among the three groups were significantly different (Figure 4; also
see File S1).
There were two newborn infants, one aged 12 days from the
neonatal ward and the other aged 18 days from ICU, whose
samples were positive for HBoV only. NPA and stool samples were
collected from the 12 day old infant and NPA, stool and whole
blood samples were collected from the 18 day old infant. The 12
day old infant had HBoV viral load of 9.06104 copies/mL in the
NPA with no HBoV detection in stool sample, whereas the 18 day
old infant had an HBoV viral load of 5.06109 copies/mL in the
NPA with HBoV positive stool and serum samples. The 18 day old
child had more severe clinical symptoms than the 12 day old child
including fever, dyspnea needing oxygen therapy and diarrhea.
Discussion
Our study in children under five in Shanghai suggests that
HBoV1 may be a causative virus for LRTI symptoms observed in
patients; symptomatic children in our study had higher viral load
than asymptomatic children, with HBoV1 viral load correlating
with disease severity in co-infected children.
To the best of our knowledge, this is the first systematic study of
the role of HBoV infection in LRTIs conducted in Shanghai.
Previous studies including children with acute respiratory tract
infections conducted in Shanghai reported HBoV infection rates
of 4.6% to 11.8% [19,20]. In our study the positive rate of HBoV
of NPAs from patients with LRTIs was 7.2% (42/583), consistent
with previous studies. Importantly, the present study reported six
patients with NPAs, serum and stool being HBoV positive. The
median viral load of NPAs for these 6 patients were significantly
higher than other HBoV-positive samples (5.16106 vs 6.36108,
p#0.05). Detection of HBoV genomic DNA in blood with high
viral load in NPAs strengthened the causal link between the virus
and disease, which agrees with findings in other studies [9,14]. The
only subtype of HBoV circulating in Shanghai was HBoV1;
HBoV2-4 were not detected. Phylogenetic analysis demonstrated
that the HBoV1 strain circulating in Shanghai is closely related to
the FZ40 and WLL-1 strains reported from Fuzhou and
Hangzhou, China. Interestingly, we found that HBoV1 co-
circulated, to a large extent, with RSVA in the study period with
peaks in autumn and winter. RSVA was the most often detected
virus in NPAs followed by HRV and AdV, correlating with viruses
co-detected with HBoV1, with 47.4% of co-infected patients being
infected with RSVA and 15.6% with HRV.
Although HBoV has been cultured in differentiated human
airway epithelial cells [21], isolation of the virus from clinical
samples has not been achieved in cell lines, with the result that our
knowledge of its replication and pathogenesis is very limited.
Recent studies have implied that HBoV DNA can exist episomally
in infected human tissues and therefore can likely establish
persistent infection in the host [22]. In our study abdominal pain
was recorded in more HBoV-positive patients than HBoV-
Table 2. Characteristics of co-infection cohort with and
without HBoV.
HBoV+ HBoV2 p Value
Study population 19 41
Age
Median (interquartile) 24M (11M, 42M) 30M (24M, 39M)
Sex
Male (%) 9 (47.4) 21 (51.2) 0.7831m
Clinical (%)
X-ray 19 (100.0) 41 (100.0)
Fever 16 (84.2) 38 (92.7) 0.2800w
Cough 15 (80.0) 31 (75.6) 0.5262w
Wheezing 3 (15.8) 4 (9.8) 0.3888w
Dyspnea 5 (26.3) 20 (48.8) 0.1035m
Abdominal pain 2 (10.5) 1 (2.4) 0.2332w
Diarrhea 2 (10.5) 2 (4.8) 0.3770w
Disease Severity (%)
mild 10 (52.6) 17 (41.5) 0.4225m
moderate 2 (10.5) 19 (46.3) 0.0073m
severe 7 (36.8) 5 (12.2) 0.0332w
HBoV= human bocaviruses; M=month; mMentel-Haenszel x2 test; wFisher exact
x2 test.
doi:10.1371/journal.pone.0062318.t002
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negative patients with 1 out 14 (7.1%) patients with low viral load,
and 3 out 25 (12.0%) with high viral load recording diarrhea
(p = 0.5453). Although the mechanisms of pathogenesis and routes
of infection of HBoV are not yet understood, some information is
available for bovine parvovirus (BPV), another member of the
genus Bocavirus that may have implications for HBoV disease. BPV
causes respiratory and enteric disease in calves following initial
replication in the tonsils and intestinal epithelium, from where it
spreads into the blood, lymphoid tissues and respiratory epithe-
lium [23].
Several seroepidemiologic studies have demonstrated that
HBoV infects 40–50% of healthy children aged 6 months to 4
years, after which there appears to be widespread immunity. The
present study chose 29 outpatients who presented to hospital for
respiratory symptoms and 195 healthy controls retrieved from
SCDC Sample Bank to analyze the HBoV positive rate and the
viral load. Outpatients and inpatients had high viral load (.16106
copies/mL) whereas the viral load of healthy controls was low.
This result confirms that HBoV can exist in the respiratory tract
without causing any symptoms; high viral load is necessary for
symptomatic disease.
Further, this study investigated the correlation between HBoV
viral load and disease severity in patients with only HBoV
infection or HBoV co-infection with other respiratory viruses. It is
noticeable that in co-infection, HBoV viral load was associated
positively with disease severity (p#0.05). Given that the most
frequently co-detected virus with HBoV was RSVA, which can
also cause severe LRTIs in children, the frequency of RSVA in
different disease severity groups was analyzed. The percentage of
RSVA co-detection with HBoV was not significantly higher than
other infectious viruses in all disease severity groups (p value: mild
0.6393, moderate 0.1006, severe 0.0670). In addition, the patients
who were negative for HBoV but infected with more than one
respiratory virus were mostly grouped with moderate disease
compared to those who were positive for HBoV (p#0.05).
Additionally, there were more HBoV-positive patients than
HBoV-negative patients (P#0.05) in the severe disease group.
Finally, our data of the two infants with HBoV suggest that LRTIs
caused by HBoV can lead to severe and life-threatening disease,
confirming reports from other studies [16,18]. To the best of our
knowledge this is the first report of severe disease in an infant
under 1 month of age with only HBoV being detected and our
data imply that HBoV1 can infect very young infants.
A few cases of severe disease caused by HBoV have been
reported previously, with suggestions that infection may be
associated with unexplained LRT symptoms [17,24]; however
the underlying mechanisms are not clear. In this study we found
an association between disease severity and HBoV1 viral load in
co-infected children; however, our study is limited by the small
number of patients and a larger study or meta-analysis is needed to
confirm this correlation. It is tempting to speculate that other
respiratory viruses which co-infect with HBoV may facilitate
Figure 3. HBoV viral loads in healthy controls, outpatients and inpatients. Healthy controls were randomly chosen from asymptomatic
children under the age of five. Outpatient NPAs were collected from children who visited the hospital due to LRTIs but were not hospitalized.
Inpatients were children admitted to hospital with LRTIs. The HBoV viral loads (DNA copies per mL) were estimated in 47 HBoV-positive samples
(including 5 healthy control, 3 outpatient and 39 inpatient samples) with HBoV real time PCR kit using Roche Light Cycler 480 as described in the text.
The positive control (161010 copies/mL) provided in the kit was used to generate a standard curve. The viral load (median with interquartile range) in
healthy controls (dark circles), outpatients (dark triangles) and inpatients (dark squares) are shown. The differences in HBoV viral load between
healthy controls and inpatients, and between healthy controls and outpatients were analyzed by Kruskal-Wallis H x2 test and are shown on the
diagram. Significance was accepted at P#0.05.
doi:10.1371/journal.pone.0062318.g003
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HBoV invasion and replication by undermining host immune
responses resulting in high levels of HBoV replication facilitating
its spread to the blood circulation to cause systemic disease;
however this remains to be proven.
Methods
Study populations
All patient samples used in this study were collected from
patients who presented with respiratory symptoms to Shanghai
Children’s Hospital from October of 2009 through August of
2012. Patients who were under 5 years of old and diagnosed with
bronchiolitis and/or pneumonia by X-ray without underlying
conditions were recruited into this study. In all 554 patients were
enrolled and their nasopharyngeal aspirates (NPAs) were collected
within 3 days of admission to hospital. Among them, 11 patients
had NPAs, stool and whole blood samples collected, 2 patients had
NPAs and stool samples collected concurrently. 64% (355/554),
10.5% (58/554) and 25.5% (141/554) of patients were inpatients
in the respiratory ward, neonatal ward and Intensive Care Unit
(ICU), respectively. Clinical information was collected by trained
staff and recorded. This study was approved by the Ethical Review
Committee of Shanghai Municipal Center for Disease Control
and Prevention (SCDC).
In 2012, we randomly collected NPAs from 29 outpatients
(under 5 years of age) with LRTIs and without any treatment from
Shanghai Children’s Hospital. Their clinical information was also
recorded. To investigate the prevalence of HBoV in healthy
children in Shanghai, 195 nasopharyngeal swabs (NPSs) from
healthy children (under 5 years of age) were randomly retrieved
from SCDC Sample Bank.
Samples treatment
All samples were collected and stored in sterile tubes and sent to
SCDC microbiology laboratory within 3 hours of collection. All
NPAs, stools and whole blood samples were tested for common
respiratory viruses, while the NPS samples were tested for HBoV.
1.5 ml sterile saline (0.9%) was added into each tube of NPA
and tubes centrifuged at 13000 rpm for 2 minutes; the supernatant
was removed and pellet resuspended in 200 mL of Eagle’s
Minimum Essential Medium. Blood samples were centrifuged at
3000 rpm for 5 minutes; plasma was isolated and kept at 270uC.
3 ml sterile saline (0.9%) was added into each tube with stool
samples, the mixture was vigorously vortexed for 5 minutes, and
centrifuged at 13000 rpm for 5 minutes. The supernatant was
aspirated and stored at 270uC.
Nucleic acid extraction and first strand cDNA synthesis
Total nucleic acid of each sample (200 ml) was isolated by the
MagNA Pure LC 2.0 (Roche, Switzerland) using MagNA Pure LC
DNA Isolation Kit (Roche, Germany) following manufacturer’s
recommendations. 60 ml of eluted total nucleic acid was used as
template for PCR. 554 NPAs, 11 serum and 13 stool samples were
used for reverse transcription using ReverAid First Strand cDNA
Synthesis Kit (Fermentas, CA) on GeneAmp PCR system 9700
(AB, Singapore) according to the manufacturer’s recommenda-
tions.
Multiplex PCR for 12 respiratory viruses
All 578 first strand cDNAs were used for multiplex PCR for 12
common respiratory viruses using Seeplex RV12 ACE detection
Kit (Seegene, Germany). The viruses included influenza A (FluA),
influenza B (FluB), respiratory syncytial viruses A (RSVA), and B
(RSVB), human metapneumovirus (hMPV), human parainfluenza
Figure 4. HBoV viral load is associated with disease severity in
co-infected patients. Disease severity was assessed according to
index of severity (IOS) as described in the text. Patients with IOS value of
0–2 were classified as having mild disease, patients with IOS value of 3–
5 were classified as having moderate disease and patients with IOS
value of 6–7 were classified as having severe disease. HBoV viral load
was measured in 39 HBoV-positive inpatient samples as described in
the legend to Figure 3. Patients with viral load of $106 copies/mL were
termed the high viral load group, and those with viral loads of ,106
copies/mL were termed the low viral load group. Statistical differences
among the mild, moderate and severe patients were analyzed by
Kruskal-Wallis H x2 test and are showed on the diagram. A. Median
HBoV viral load (with interquartile range) of mild (dark squares),
moderate (dark triangles) and severe (dark stars) inpatients with mono-
infection with HBoV1. B. Median HBoV viral load (with interquartile
range) of mild (dark squares), moderate (dark triangles) and severe (dark
stars) inpatients with co-infection with HBoV1 and at least one other
respiratory virus.
doi:10.1371/journal.pone.0062318.g004
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viruses 1, 2 and 3 (PIV-1,2,3), adenovirus (AdV), human
rhinovirus A/B (HRVA/B), human coronavirus 229E/NL63,
human coronavirus OC43/HKU1. PCR conditions were as per
the manufacturer’s protocols and performed on GeneAmp PCR
system 9700 (AB, Singapore). Positive and negative controls
provided by the company were included in each test.
Real-time PCR for HBoV subtypes and viral load
Real time PCR for HBoV subtypes was performed in all
samples using previously published primers and probes for
HBoV1-4 [25]. PCR was performed in a volume of 20 ml using
Roche Light Cycler 480 (Roche, Switzerland) and PCR optical 96-
well reaction plate (Roche, Switzerland). Each reaction consisted
of 10 ml Premix EX Taq (Takara, Japan), 0.4 ml each of sense and
antisense primers (10 mM), 0.8 ml probe (20 mM), 6.4 ml DEPC-
treated water and 2 ml of DNA template for a final volume of
20 ml. The PCR mix was denatured at 95uC for 30 seconds (s),
followed by amplification consisting of 40 cycles of 15 s at 95uC
and 1 minute at 60uC. Positive and no-template controls were
included in each run. Plasmids containing the target genes were
used as positive controls for all four HBoV subtypes and were
constructed by Bio-Sune Bio-tech company.
Real time PCR for HBoV viral load was performed in 39
HBoV-positive samples using HBoV real time PCR kit (Shanghai
ZJ Bio-Tech Co., Ltd., People’s Republic of China) using Roche
Light Cycler 480 (Roche, Switzerland). Positive, negative and no-
template controls provided in the kit were included in each test.
The positive control (161010 copies/ml) provided in the kit was
used to generate a standard curve. The concentration of each
detected sample was then calculated automatically according to
standard curve by Roche Light Cycler 480.
PCR for complete genome sequence
The complete genome of HBoV1 is 5299 nucleotide (nt) long; 5
primer pairs were designed to amplify 5 overlapping fragments,
covering the whole genome (see Table 3 for primer sequences),
and synthesized by Bio-Sune Bio-tech company (Shanghai,
China). The conserved and variable regions of the HBoV1
genome were identified by aligning 13 HBoV1 sequences
downloaded from Genbank. Primer selection was aided by
Lasergene PrimerSelect 7.0.1 software (DNASTAR, inc., CA)
for maximum homology. The primer pairs were specific for
HBoV1, with no homology found to any other sequences in
GenBank. Premix Ex Taq Version 2.0 (Takara, Japan) was used to
perform PCR in a volume of 50 ml using GeneAmp PCR system
9700 (AB, Singapore) and optical 96-well reaction plate (AB,
Singapore). Each reaction consisted of 25 ml Premix EX Taq, 1 ml
each of sense and antisense primers (20 mM), 5 ml HBoV DNA,
and molecular grade water to a final volume of 50 ml. PCR
consisted of 35 cycles of 15 minutes at 94uC; 30 s at 94uC, 30 s at
45–55uC, 1 minute at 72uC followed by 10 minutes at 72uC. The
PCR products were visualized by electrophoresis on a 2% agarose
gel containing 0.5 mg/ml ethidium bromide in Tris-borate buffer
(pH 8.0). Positive PCR products were purified and sequenced by
Bio-Sune bio-tech. Sequences were spliced in silico using Lasergene
SeqMan 7.0.1 software (DNASTAR, inc., CA). The phylogenetic
tree of HBoV sequences was constructed using neighbor-joining
by MEGA (5.0 version) software. 6 sequences of HBoV1, 3
HBoV2 sequences, 3 HBoV3 sequences and 2 HBoV4 sequences
were downloaded from Genbank and used as the reference viruses
in the construction of the tree.
Disease severity
All patients recruited into this study were admitted for LRTIs
and were diagnosed with bronchiolitis and/or pneumonia. Disease
severity was assessed according to index of severity (IOS) [26],
based on potential of hydrogen (PH), partial pressure CO2 (PCO2),
partial pressure O2 (PO2), need for hospitalization, oxygen therapy
and positive airway pressure, not including length of hospital stay.
Patients with an IOS value of 0–2 were classified as having mild
disease, patients with an IOS value of 3–5 were classified as having
moderate disease and patients with an IOS value of 6–7 were
classified as having severe disease.
Statistical analysis
Statistical analysis was performed using the Epi Info software
(version 3.5, CDC, USA), and graphs were prepared using Prism
Graphpad v5. Mentel-Haenszel, Kruskal-Wallis x2 or Fisher’s
exact x2 test were used to assess the significance; p value #0.05
was considered statistically significant for all tests.
Supporting Information
File S1 Supporting Information for Figure 4. Viral load (a)
and descriptive statistical analysis (b) is presented for study subjects
infected with HBoV1 and one other virus (1) or with HBoV1 alone
(2).
(DOC)
Table 3. Primers sequence for HBoV1 genome sequencing.
Complete genome (FZ1/GQ455988) Sequence(59-39) Position*
Fragment1 F1-GCCGGCAGACATATTGGATTCC 1
R1-CTACCTCAGGAAGATGTTC 1099
Fragment2 F2-CCTAGATAACGAAGTCATTC 1041
R2-AATCAGTGCAGTATCCGTTTTC 2059
Fragment3 F3-AAACTCATTTCCTCTTGG 2001
R3-CAGCAGCAGAAAGCATTTC 3022
Fragment4 F4-GTACCGTAGACACTTAGCTAATG 2962
R4-TCTGTAGCATTGCCTCCAG 4062
Fragment5 F5-CTTTTTCAATATGGATATATTCC 4001
R5-TGTACAACAACAACATTAAAA 5279
*Position is defined by strain FZ40 (GeneBank NO. GQ455987) as target gene.
doi:10.1371/journal.pone.0062318.t003
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